Edgewise Therapeutics (EWTX) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free EWTX Stock Alerts $18.77 +0.66 (+3.64%) (As of 05:29 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Edgewise Therapeutics Short Interest DataCurrent Short Interest6,520,000 sharesPrevious Short Interest5,760,000 sharesChange Vs. Previous Month+13.19%Dollar Volume Sold Short$116.97 millionShort Interest Ratio8.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares93,400,000 sharesFloat Size62,940,000 sharesShort Percent of Float10.36%Today's Trading Volume413,194 sharesAverage Trading Volume888,707 sharesToday's Volume Vs. Average46% Short Selling Edgewise Therapeutics ? Sign up to receive the latest short interest report for Edgewise Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEWTX Short Interest Over TimeEWTX Days to Cover Over TimeEWTX Percentage of Float Shorted Over Time Ad Huge Alerts**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report Edgewise Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,520,000 shares $116.97 million +13.2%10.4%8.9 $17.94 4/15/20245,760,000 shares $94.92 million +0.7%9.2%7.6 $16.48 3/31/20245,720,000 shares $104.33 million +27.7%9.1%5.7 $18.24 3/15/20244,480,000 shares $75.80 million -18.0%7.1%4.3 $16.92 2/29/20245,460,000 shares $89.16 million +6.4%9.1%5.6 $16.33 2/15/20245,130,000 shares $93.98 million -5.0%8.6%5.4 $18.32 Get the Latest News and Ratings for EWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20245,400,000 shares $96.28 million -33.9%11.5%6.3 $17.83 1/15/20248,170,000 shares $81.70 million -12.5%22.7%10.8 $10.00 12/31/20239,340,000 shares $102.18 million +9.9%25.9%20.1 $10.94 12/15/20238,500,000 shares $61.97 million +20.9%23.7%22.6 $7.29 11/30/20237,030,000 shares $42.74 million +11.1%19.6%24.7 $6.08 11/15/20236,330,000 shares $41.52 million +5.3%17.7%34.2 $6.56 10/31/20236,010,000 shares $38.46 million +4.5%17.0%35.9 $6.40 10/15/20235,750,000 shares $38.58 million +1.6%16.3%36.2 $6.71 9/30/20235,660,000 shares $32.43 million +2.2%16.1%33.2 $5.73 9/15/20235,540,000 shares $35.57 million +1.7%15.7%28.2 $6.42 8/31/20235,450,000 shares $34.06 million +1.1%13.9%26.9 $6.25 8/15/20235,390,000 shares $39.35 million -1.3%13.8%24.5 $7.30 7/31/20235,460,000 shares $39.80 million -12.1%13.7%24.8 $7.29 7/15/20236,210,000 shares $44.84 million +11.7%15.6%27.4 $7.22 6/30/20235,560,000 shares $43.09 million +3.5%14.0%26.4 $7.75 6/15/20235,370,000 shares $46.83 million +12.6%13.5%25 $8.72 5/31/20234,770,000 shares $48.27 million +5.8%12.0%25.3 $10.12 5/15/20234,510,000 shares $40.68 million +1.8%11.3%25.8 $9.02 4/30/20234,430,000 shares $38.85 million +6.2%11.0%25.6 $8.77 4/15/20234,170,000 shares $24.23 million +4.5%10.3%26.5 $5.81 3/31/20233,990,000 shares $26.61 million +6.1%9.9%25.1 $6.67 3/15/20233,760,000 shares $28.76 million -2.1%9.3%25.4 $7.65 2/28/20233,840,000 shares $36.79 million +1.6%9.5%22.4 $9.58 2/15/20233,780,000 shares $37.76 million -2.3%9.3%21.3 $9.99 1/31/20233,870,000 shares $39.59 million +29.9%9.6%21.5 $10.23 1/15/20232,980,000 shares $32.93 million -25.7%7.4%15.8 $11.05 12/30/20224,010,000 shares $35.85 million +38.8%10.0%20 $8.94 12/15/20222,890,000 shares $22.46 million -16.2%7.2%13.3 $7.77 11/30/20223,450,000 shares $30.88 million -3.1%8.6%11.8 $8.95 11/15/20223,560,000 shares $37.38 million -1.1%8.9%12 $10.50 10/31/20223,600,000 shares $34.24 million +8.4%8.9%12.1 $9.51 10/15/20223,320,000 shares $34.59 million +19.0%10.4%10.9 $10.42 9/30/20222,790,000 shares $27.45 million +5.3%10.2%9.2 $9.84 9/15/20222,650,000 shares $24.19 million -12.3%9.7%8.3 $9.13Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. 8/31/20223,020,000 shares $30.44 million -17.0%10.8%12.3 $10.08 8/15/20223,640,000 shares $39.17 million +3.7%13.1%14.7 $10.76 7/31/20223,510,000 shares $33.94 million +3.2%12.5%13.5 $9.67 7/15/20223,400,000 shares $34.54 million +9.0%12.1%13.3 $10.16 6/30/20223,120,000 shares $24.84 million -3.1%11.1%12.6 $7.96 6/15/20223,220,000 shares $19.90 million +1.6%11.5%13.2 $6.18 5/31/20223,170,000 shares $19.81 million -16.1%11.3%14.8 $6.25 5/15/20223,780,000 shares $29.60 million -3.3%13.6%16.7 $7.83 4/30/20223,910,000 shares $31.20 million +1.8%14.0%18.4 $7.98 4/15/20223,840,000 shares $33.48 million -5.9%13.8%16.5 $8.72 3/31/20224,080,000 shares $39.58 million -2.9%14.7%14.7 $9.70 3/15/20224,200,000 shares $42.97 million -10.6%15.1%10.8 $10.23 2/28/20224,700,000 shares $55.41 million +4.7%16.9%10.2 $11.79 2/15/20224,490,000 shares $58.95 million +12.5%18.6%9.8 $13.13 1/31/20223,990,000 shares $54.26 million +8.7%16.5%9.1 $13.60 1/15/20223,670,000 shares $64.23 million +4.6%N/A8.8 $17.50 12/31/20213,510,000 shares $53.63 million +31.0%14.5%9.2 $15.28 12/15/20212,680,000 shares $51.97 million +24.1%11.1%11.8 $19.39 11/30/20212,160,000 shares $37.63 million +45.0%8.9%16.8 $17.42 11/15/20211,490,000 shares $29.25 million +7.2%6.1%15.6 $19.63 10/29/20211,390,000 shares $22.94 million -12.0%5.9%16.7 $16.50 10/15/20211,580,000 shares $28.03 million No Change6.7%23.5 $17.74 9/30/20211,580,000 shares $26.23 million -1.3%6.7%17.2 $16.60 9/15/20211,600,000 shares $25.39 million -23.8%6.9%12.1 $15.87 8/31/20212,100,000 shares $33.26 million +2.4%9.0%12.6 $15.84 8/13/20212,050,000 shares $33.33 million No Change8.8%11 $16.26 EWTX Short Interest - Frequently Asked Questions What is Edgewise Therapeutics' current short interest? Short interest is the volume of Edgewise Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 6,520,000 shares of EWTX short. 10.36% of Edgewise Therapeutics' shares are currently sold short. Learn More on Edgewise Therapeutics' current short interest. What is a good short interest ratio for Edgewise Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EWTX shares currently have a short interest ratio of 9.0. Learn More on Edgewise Therapeutics's short interest ratio. What is a good short interest percentage for Edgewise Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.36% of Edgewise Therapeutics' floating shares are currently sold short. Is Edgewise Therapeutics' short interest increasing or decreasing? Edgewise Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 6,520,000 shares, an increase of 13.2% from the previous total of 5,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edgewise Therapeutics' float size? Edgewise Therapeutics currently has issued a total of 93,400,000 shares. Some of Edgewise Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edgewise Therapeutics currently has a public float of 62,940,000 shares. How does Edgewise Therapeutics' short interest compare to its competitors? 10.36% of Edgewise Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Edgewise Therapeutics: Structure Therapeutics Inc. (10.35%), Kura Oncology, Inc. (13.59%), Supernus Pharmaceuticals, Inc. (9.16%), Taro Pharmaceutical Industries Ltd. (0.68%), Spyre Therapeutics, Inc. (12.81%), Schrödinger, Inc. (9.65%), Arcus Biosciences, Inc. (16.36%), Harmony Biosciences Holdings, Inc. (16.05%), Ligand Pharmaceuticals Incorporated (4.42%), Protagonist Therapeutics, Inc. (6.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Edgewise Therapeutics stock? Short selling EWTX is an investing strategy that aims to generate trading profit from Edgewise Therapeutics as its price is falling. EWTX shares are trading up $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edgewise Therapeutics? A short squeeze for Edgewise Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EWTX, which in turn drives the price of the stock up even further. How often is Edgewise Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EWTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Structure Therapeutics Short Squeeze Kura Oncology Short Squeeze Supernus Pharmaceuticals Short Squeeze Taro Pharmaceutical Industries Short Squeeze Spyre Therapeutics Short Squeeze Schrödinger Short Squeeze Arcus Biosciences Short Squeeze Harmony Biosciences Short Squeeze Ligand Pharmaceuticals Short Squeeze Protagonist Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EWTX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our Partners"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company